MarketReportsOnline.com adds "Global Intravenous (I.V.) Iron Drugs Market Report: 2015 Edition" report to its research store.

Dallas, TX -- (SBWire) -- 06/08/2015 --Iron deficiency anemia is the most common form of anemia throughout the world. It is estimated that two billion people suffer from iron deficiency anemia worldwide. To address iron deficiency, iron therapy is important being the critical factor in the production of red blood cells. Around 4.5 million Americans are diagnosed and suffering from iron deficiency anemia (IDA).

Generally, daily oral iron is the first line therapy for most IDA patient but for many patients oral iron therapy fails as a consequence of compliance, efficacy and side effects like constipation and gastro intestinal disorders. When oral supplements fail to meet the requirement, intravenous (I.V.) iron therapy is used, in which iron is directly injected with a needle into a vein.

Complete report available at http://www.marketreportsonline.com/411242.html.

Iron given intravenously allows larger amounts of iron to be provided to patients while avoiding many of the side effects and treatment compliance issues associated with oral iron, and can result in faster rises in hemoglobin levels. In the US, a small fraction of non-dialysis CKD patients who are diagnosed with IDA are currently being treated with I.V. iron, and thus a significant opportunity is there for the market.

The key factors driving growth of the global I.V. iron industry include iron deficiency in hemodialysis patient cases, growing number of ERSD patients, prevalence of iron deficiency in women, increasing global healthcare expenditure, increasing global ageing population and large potential in new therapeutic areas. Some of the noteworthy trends and developments of this industry are penetration of I.V. iron in obstetrics and gynecology area, new product development and increase in awareness of disease. However, the growth of this sector is hindered by potential risks of using I.V. iron, emerging anemia management therapies and strict regulatory structures.

Order a copy of "Intravenous (I.V.) Iron Drugs Market" research report at USD 800 (Single User License)
http://www.marketreportsonline.com/contacts/purchase.php?name=411242

The report provides a comprehensive study of iron product market and I.V. iron market globally. It also provides detailed information for key regional markets of I.V iron industry. The competition in the global I.V. iron market is stiff among large players like Galenica Group, AMAG Pharmaceuticals Inc. and Actavis Plc. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

Major points from Table of Contents are listed below:
1. Overview
2. Market Analysis
3. Market Dynamics
4. Competitive Landscape
5. Company Profiles
6. Market Outlook

List of Tables

Risk Factors for CKD
Emerging Non-Intravenous Therapies for Anemia Management
I.V. Iron Product Comparison
Dependent & Independent Variables (2010-2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Other Related Reports on Pharmaceuticals Market:

Global Hemophilia Market Report: 2015 Edition (http://www.marketreportsonline.com/409838.html) Hemophilia is an inherited or acquired bleeding disorder that prevents blood from clotting. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. People with hemophilia do not bleed any faster than normal, but they can bleed for a longer time.

US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition (http://www.marketreportsonline.com/395328.html) The PBM providers control drug spending and utilization by virtue of their advanced tools and techniques, encouraging use of generics and other lower-cost medications. In the US, there are some independent PBM's while some are owned by managed care organizations and retail pharmacies. Today, the PBM industry has become more determined through a series of mergers and acquisitions.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
Corporate Office
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: 888-391-5441
E-mail: sales@marketreportsonline.com